Who owns SENTI BIOSCIENCES INC?
- Ticker: SNTI
- CUSIP Number: 81726a209
Tip: Access positions for across all investors
Analyze quarterly positions in Senti Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Senti Biosciences stock
Who bought or sold SENTI BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 3.8M | $3.1M | 0% | Mar 2026 |
|
| Nantahala Capital Management | 888k | $721k | 0% | Mar 2026 |
|
| Vanguard Group | 629k | $654k | 2% | Dec 2025 |
|
| Vanguard Capital Management | 538k | $437k | 100% | Mar 2026 |
|
| Geode Capital Management | 207k | $168k | 43% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 91k | $74k | 100% | Mar 2026 |
|
| Virtu Financial | 44k | $46k | 100% | Dec 2025 |
|
| Menlo Ventures Management | 36k | $29k | 100% | Mar 2026 |
|
| BlackRock | 25k | $20k | 7% | Mar 2026 |
|
| Northern Trust | 17k | $17k | 3% | Dec 2025 |
|
| Hrt Financial | 15k | $12k | 100% | Mar 2026 |
|
| Goss Wealth Management | 12k | $9.7k | 100% | Mar 2026 |
|
| State Street Corporation | 10k | $10k | 0% | Dec 2025 |
|
| UBS Group | 8.6k | $7.0k | 91% | Mar 2026 |
|
| Tower Research Capital | 3.4k | $3.5k | 97% | Dec 2025 |
|
| SBI Securities | 334.00 | $271.007600 | -1% | Mar 2026 |
|
| Morgan Stanley | 160.00 | $130.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Senti Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 38k | $40k |
| XTX Topco | Sep 2025 | 27k | $38k |